GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹94 Cr | ₹116 Cr |
| Adjustment | ₹44 Cr | ₹34 Cr |
| Changes In working Capital | ₹7.44 Cr | ₹-130 Cr |
| Cash Flow after changes in Working Capital | ₹145 Cr | ₹20 Cr |
| Cash Flow from Operating Activities | ₹123 Cr | ₹-7.46 Cr |
| Cash Flow from Investing Activities | ₹-71 Cr | ₹-102 Cr |
| Cash Flow from Financing Activities | ₹-37 Cr | ₹82 Cr |
| Net Cash Inflow / Outflow | ₹15 Cr | ₹-27 Cr |
| Opening Cash & Cash Equivalents | ₹1.14 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹16 Cr | ₹1.14 Cr |
Compare Cashflow Statement of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,912.7 Cr | 7.1% | -6.3% | -18.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | 7.1% |
-6.3% |
-18.7% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses